2 min
Seeing the light. What is photobiomodulation and how is it changing the way we treat the brain?
As prospects for pharmaceutical solutions to Alzheimer's decline with no solution in sight over the next five years could this daunting challenge be a catalyst for acceleration of alternative therapies? Vielight, partnering with leading health research institutions in North America has now attracted worldwide attention for its unique light therapy (photobiomodulation) technology which is showing promise for a number neurological conditions. Photobiomodulation uses visible red and near infrared light energy stimulates cells to generate more energy and undergo self-repair. The concept is not new, but advanced technologies and applications have allowed this form of therapy to emerge as a new leader in treating brain trauma and afflictions and diseases such as dementia and Alzheimer’s. The first large scale human clinical trial kicks off this year in Toronto but patients and families have already seen astounding results. Health research institutions are making serious investments in light therapy research related to variety of neurological conditions and treatments such as Alzheimer's, dementia and Parkinson's. Researchers at institutions such as Harvard, UCSF and the Centre for Addiction and Mental Health in Toronto are discovering profound neurological effects of Vielight technology to support treatment options for Alzheimer’s and Dementia, PTSD and Traumatic brain Injury. There are a lot of questions and there is still a lot to learn about this emerging technology as well as the advancements that are taking place as we learn more about the brain and how to treat it. That’s where the experts from Vielight can help. Simply click on the icons of one of the many experts from Vielight to arrange an interview or learn more about photobiomodulation and how light therapy is being used to treat patients around the world. Source:
